Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@dose_of_naz Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1244166951045402625.png) @dose_of_naz Dr. Nazifa Kadery, PharmD, RPh

Dr. Nazifa Kadery, PharmD, RPh posts on X about $4523t, kite, $620m, stocks the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1244166951045402625/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:interactions.svg)

- X Week XXX +37%
- X Month XXXXX +2,713%
- X Months XXXXX +82%
- X Year XXXXX +170%

### Mentions: XX [#](/creator/twitter::1244166951045402625/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +1,300%
- X Months XXX +139%
- X Year XXX +246%

### Followers: XXX [#](/creator/twitter::1244166951045402625/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:followers.svg)

- X Week XXX +0.73%
- X Month XXX +7%
- X Months XXX +35%
- X Year XXX +42%

### CreatorRank: undefined [#](/creator/twitter::1244166951045402625/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance) 

**Social topic influence**
[$4523t](/topic/$4523t) #23, [kite](/topic/kite), [$620m](/topic/$620m), [stocks](/topic/stocks), [regeneron](/topic/regeneron), [ai](/topic/ai), [$abbv](/topic/$abbv)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv)
### Top Social Posts
Top posts by engagements in the last XX hours

"New Data Presented at #CTAD2025 Confirms Pharmacological Effect of #LEQEMBI (#lecanemab-irmb) on Neurotoxic A Protofibrils in #CSF #Eisai #Biogen #MedTwitter #Neurology #Neurodegeneration"  
[X Link](https://x.com/dose_of_naz/status/1996234945837076989)  2025-12-03T15:07Z XXX followers, XXX engagements


"#Kite Announces New Data for Pivotal iMMagine-1 Study at #ASH25 Highlighting Anito-cels Opportunity in Relapsed or Refractory #MultipleMyeloma #MedTwitter #Hematology #Oncology via @Gilead"  
[X Link](https://x.com/dose_of_naz/status/1997717796583883175)  2025-12-07T17:20Z XXX followers, XX engagements


"#Kites next-gen bicistronic CAR T-Cell tx show encouraging Ph1 results in r/r B-Cell #Lymphoma in new data at #ASH2025 #MedTwitter #Hematology #Oncology"  
[X Link](https://x.com/dose_of_naz/status/1997718248411033886)  2025-12-07T17:22Z XXX followers, XX engagements


"Mirum Pharma pays $620M to buy Bluejay Tx & its Ph3 #hepatitis drug #brelovitug (IgG1 #mAb that targets the surface antigen on both #HDV & #HBV) #MedTwitter #InfectiousDisease"  
[X Link](https://x.com/dose_of_naz/status/1998205021016703342)  2025-12-09T01:36Z XXX followers, XX engagements


"New Ph3: A Research Study on How Well #Cagrilintide and #CagriSema Work in #Children and #Adolescents With Excess Body Weight #MedTwitter #Cardiometabolic #NovoNordisk #ClinicalTrial #GLP1 #Obesity #WeightLoss"  
[X Link](https://x.com/dose_of_naz/status/1996230004670165026)  2025-12-03T14:48Z XXX followers, XX engagements


"Wave Structure stocks double on #obesity data readouts #MedTwitter #Obesity #Cardiometabolic #GLP1"  
[X Link](https://x.com/dose_of_naz/status/1998204102044778930)  2025-12-09T01:32Z XXX followers, XX engagements


"#ASH25: #Regeneron eyes simpler regimens in bid to move #bispecifics into earlier #bloodcancer tx #MedTwitter #Hematology #Oncology #DLBCL"  
[X Link](https://x.com/dose_of_naz/status/1998206494597361961)  2025-12-09T01:42Z XXX followers, XX engagements


"#Eisai Presents New Data on Anti-Tau Antibody #Etalanetug (E2814) at #CTAD2025 #MedTwitter #Alzheimers #Neurology"  
[X Link](https://x.com/dose_of_naz/status/1996237135649661298)  2025-12-03T15:16Z XXX followers, XXX engagements


"#GE HealthCare #MayoClinic launch digital twin project for personalizing #radiation cancer therapy #MedTwitter #Oncology #Radiology #AI #Cancer"  
[X Link](https://x.com/dose_of_naz/status/1996753969641644508)  2025-12-05T01:30Z XXX followers, XX engagements


"#Vertex Presents New Data on #CASGEVY Including First-Ever Data in #Children Ages 5-11 Years at #ASH25 and Announces Plan for Global Regulatory Submissions #MedTwitter #Hematology #SickleCell #BetaThalassemia"  
[X Link](https://x.com/dose_of_naz/status/1997719877214523855)  2025-12-07T17:28Z XXX followers, XX engagements


"#AbbVie to Feature New Data at #ASH25 Showcasing Continued Advances Across Novel Tx Modalities in Multiple Blood #Cancers #MedTwitter #Hematology #Oncology"  
[X Link](https://x.com/dose_of_naz/status/1997720117665517695)  2025-12-07T17:29Z XXX followers, XX engagements


"Dr. Reddys is paying $XX million upfront for the rights to Immuteps Ph3-stage LAG-3 candidate (#eftilagimod) in certain territories #MedTwitter #Oncology #HNSCC #NSCLC #Immunotherapy #Cancer"  
[X Link](https://x.com/dose_of_naz/status/1998202960745242812)  2025-12-09T01:28Z XXX followers, XX engagements


"Ph3 HER2CLIMB-05: Adding #TUKYSA to 1L maintenance tx (trastuzumab + pertuzumab) in #HER2+ #mBC reduces the risk of disease progression or death by XX% vs. PCB (trastuzumab + pertuzumab) #SABCS25 #MedTwitter #Oncology #Pfizer #BreastCancer #TKI"  
[X Link](https://x.com/dose_of_naz/status/1998912945972195441)  2025-12-11T00:29Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@dose_of_naz Avatar @dose_of_naz Dr. Nazifa Kadery, PharmD, RPh

Dr. Nazifa Kadery, PharmD, RPh posts on X about $4523t, kite, $620m, stocks the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX +37%
  • X Month XXXXX +2,713%
  • X Months XXXXX +82%
  • X Year XXXXX +170%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX +1,300%
  • X Months XXX +139%
  • X Year XXX +246%

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.73%
  • X Month XXX +7%
  • X Months XXX +35%
  • X Year XXX +42%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks finance

Social topic influence $4523t #23, kite, $620m, stocks, regeneron, ai, $abbv

Top assets mentioned AbbVie Inc (ABBV)

Top Social Posts

Top posts by engagements in the last XX hours

"New Data Presented at #CTAD2025 Confirms Pharmacological Effect of #LEQEMBI (#lecanemab-irmb) on Neurotoxic A Protofibrils in #CSF #Eisai #Biogen #MedTwitter #Neurology #Neurodegeneration"
X Link 2025-12-03T15:07Z XXX followers, XXX engagements

"#Kite Announces New Data for Pivotal iMMagine-1 Study at #ASH25 Highlighting Anito-cels Opportunity in Relapsed or Refractory #MultipleMyeloma #MedTwitter #Hematology #Oncology via @Gilead"
X Link 2025-12-07T17:20Z XXX followers, XX engagements

"#Kites next-gen bicistronic CAR T-Cell tx show encouraging Ph1 results in r/r B-Cell #Lymphoma in new data at #ASH2025 #MedTwitter #Hematology #Oncology"
X Link 2025-12-07T17:22Z XXX followers, XX engagements

"Mirum Pharma pays $620M to buy Bluejay Tx & its Ph3 #hepatitis drug #brelovitug (IgG1 #mAb that targets the surface antigen on both #HDV & #HBV) #MedTwitter #InfectiousDisease"
X Link 2025-12-09T01:36Z XXX followers, XX engagements

"New Ph3: A Research Study on How Well #Cagrilintide and #CagriSema Work in #Children and #Adolescents With Excess Body Weight #MedTwitter #Cardiometabolic #NovoNordisk #ClinicalTrial #GLP1 #Obesity #WeightLoss"
X Link 2025-12-03T14:48Z XXX followers, XX engagements

"Wave Structure stocks double on #obesity data readouts #MedTwitter #Obesity #Cardiometabolic #GLP1"
X Link 2025-12-09T01:32Z XXX followers, XX engagements

"#ASH25: #Regeneron eyes simpler regimens in bid to move #bispecifics into earlier #bloodcancer tx #MedTwitter #Hematology #Oncology #DLBCL"
X Link 2025-12-09T01:42Z XXX followers, XX engagements

"#Eisai Presents New Data on Anti-Tau Antibody #Etalanetug (E2814) at #CTAD2025 #MedTwitter #Alzheimers #Neurology"
X Link 2025-12-03T15:16Z XXX followers, XXX engagements

"#GE HealthCare #MayoClinic launch digital twin project for personalizing #radiation cancer therapy #MedTwitter #Oncology #Radiology #AI #Cancer"
X Link 2025-12-05T01:30Z XXX followers, XX engagements

"#Vertex Presents New Data on #CASGEVY Including First-Ever Data in #Children Ages 5-11 Years at #ASH25 and Announces Plan for Global Regulatory Submissions #MedTwitter #Hematology #SickleCell #BetaThalassemia"
X Link 2025-12-07T17:28Z XXX followers, XX engagements

"#AbbVie to Feature New Data at #ASH25 Showcasing Continued Advances Across Novel Tx Modalities in Multiple Blood #Cancers #MedTwitter #Hematology #Oncology"
X Link 2025-12-07T17:29Z XXX followers, XX engagements

"Dr. Reddys is paying $XX million upfront for the rights to Immuteps Ph3-stage LAG-3 candidate (#eftilagimod) in certain territories #MedTwitter #Oncology #HNSCC #NSCLC #Immunotherapy #Cancer"
X Link 2025-12-09T01:28Z XXX followers, XX engagements

"Ph3 HER2CLIMB-05: Adding #TUKYSA to 1L maintenance tx (trastuzumab + pertuzumab) in #HER2+ #mBC reduces the risk of disease progression or death by XX% vs. PCB (trastuzumab + pertuzumab) #SABCS25 #MedTwitter #Oncology #Pfizer #BreastCancer #TKI"
X Link 2025-12-11T00:29Z XXX followers, XX engagements

creator/x::dose_of_naz
/creator/x::dose_of_naz